BRIEF published on 01/12/2026 at 15:01, 3 months 26 days ago Eckert & Ziegler participeront à la conférence JP Morgan Healthcare Conférence Sur Les Soins De Santé JP Morgan Eckert Et Ziegler Composants Isotopiques Radiopharmaceutique
BRIEF published on 01/12/2026 at 15:01, 3 months 26 days ago Eckert & Ziegler to Attend J.P. Morgan Healthcare Conference Eckert & Ziegler Healthcare Conference J.P. Morgan Radiopharmaceutical Isotope Components
PRESS RELEASE published on 01/12/2026 at 14:56, 3 months 26 days ago Eckert & Ziegler to Participate in the 44th Annual J.P. Morgan Healthcare Conference Eckert & Ziegler SE to participate in the 44th Annual J.P. Morgan Healthcare Conference. Dr. Harald Hasselmann, CEO, will present on 14 January 2026 in San Francisco, CA Healthcare Conference Eckert & Ziegler SE J.P. Morgan Healthcare Conference Dr. Harald Hasselmann
BRIEF published on 01/08/2026 at 09:05, 3 months 30 days ago Eckert et Ziegler : Un argument convaincant en faveur de l’investissement malgré la volatilité des marchés Croissance Investissement Produits Radiopharmaceutiques Performance Boursière Radio-isotopes
BRIEF published on 01/08/2026 at 09:05, 3 months 30 days ago Eckert & Ziegler: A Strong Case for Investment Amidst Market Volatility Investment Growth Radiopharmaceuticals Stock Performance Radioisotopes
PRESS RELEASE published on 01/08/2026 at 09:00, 3 months 30 days ago Original-Research: Eckert & Ziegler SE (von NuWays AG): BUY Initiation research by NuWays AG recommends buying Eckert & Ziegler SE (DE0005659700) with a target price of EUR 23, citing growth in targeted radiopharmaceuticals market and unique business positioning Buy Recommendation Target Price Eckert & Ziegler SE Radiopharmaceuticals Initiation Research
BRIEF published on 12/05/2025 at 16:15, 5 months 2 days ago Executive Board Restructuring at Eckert & Ziegler Executive Board Eckert & Ziegler Restructuring Nuclear Medicine Isotope Products
BRIEF published on 12/05/2025 at 16:15, 5 months 2 days ago Restructuration du conseil d'administration chez Eckert & Ziegler Conseil D'administration Restructuration Médecine Nucléaire Produits Isotopiques Eckert Et Ziegler
PRESS RELEASE published on 12/05/2025 at 16:10, 5 months 2 days ago Reorganization of the Eckert & Ziegler Executive Board Eckert & Ziegler SE to reorganize Executive Board, reducing from three to two members, effective January 1, 2026. Frank Yeager's contract to end on Dec 31, 2025, continuing in Isotope Products role Executive Board Reorganization Eckert & Ziegler SE Isotope Products Frank Yeager
BRIEF published on 12/03/2025 at 09:05, 5 months 4 days ago Eckert & Ziegler and SK Biopharmaceuticals Form Actinium-225 Partnership Oncology Eckert & Ziegler Radiopharmaceuticals Actinium-225 SK Biopharmaceuticals
Published on 05/07/2026 at 18:30, 1 hour 16 minutes ago Silver Storm Announces Mobilization of Underground Mine Development Contractors at La Parrilla
Published on 05/07/2026 at 16:35, 3 hours 11 minutes ago Caledonia Mining Corporation Plc New Corporate Video
Published on 05/07/2026 at 15:15, 4 hours 31 minutes ago ACCESS Newswire Launches ACCESS Insights & Analytics, AI-Powered Press Release Scoring Platform
Published on 05/07/2026 at 14:35, 5 hours 11 minutes ago Worksport (NASDAQ: WKSP) Announces Q1 2026 Earnings Call Date and Launch of Investor Townhall Series
Published on 05/07/2026 at 14:30, 5 hours 16 minutes ago Rio Grande Resources Announces Results of First Annual General Meeting and Re-Appointments
Published on 05/07/2026 at 18:35, 1 hour 11 minutes ago Seminole Hard Rock Casino Named Official Miami World Cup 2026™ Host City Supporter
Published on 05/07/2026 at 18:00, 1 hour 46 minutes ago Correction d’un communiqué du 05.05.2026 21:46 CET/CEST - E-PANGO: Composition du capital au 30 avril 2026
Published on 05/07/2026 at 17:45, 2 hours 1 minute ago Swiss Life shareholders approve all resolutions proposed by the Board of Directors
Published on 05/07/2026 at 19:15, 31 minutes ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 31 minutes ago Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 40 minutes ago Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 40 minutes ago Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 46 minutes ago ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
